Medpace Holdings Inc (MEDP) - Total Liabilities
Based on the latest financial reports, Medpace Holdings Inc (MEDP) has total liabilities worth $1.53 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Medpace Holdings Inc - Total Liabilities Trend (2014–2025)
This chart illustrates how Medpace Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Medpace Holdings Inc to evaluate short-term liquidity relative to the company's equity base.
Medpace Holdings Inc Competitors by Total Liabilities
The table below lists competitors of Medpace Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
DaVita HealthCare Partners Inc
NYSE:DVA
|
USA | $16.45 Billion |
|
Apollo Hospitals Enterprise Limited
NSE:APOLLOHOSP
|
India | Rs123.97 Billion |
|
Huazhu Group Ltd
NASDAQ:HTHT
|
USA | $51.53 Billion |
|
Jinduicheng Molybdenum Co Ltd
SHG:601958
|
China | CN¥2.85 Billion |
|
HMM Co Ltd
KO:011200
|
Korea | ₩6.50 Trillion |
|
Shandong Sinocera Func Material
SHE:300285
|
China | CN¥2.24 Billion |
|
Lamar Advertising Company
NASDAQ:LAMR
|
USA | $5.93 Billion |
|
Neurocrine Biosciences Inc
NASDAQ:NBIX
|
USA | $1.38 Billion |
Liability Composition Analysis (2014–2025)
This chart breaks down Medpace Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Medpace Holdings Inc worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.72 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medpace Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medpace Holdings Inc (2014–2025)
The table below shows the annual total liabilities of Medpace Holdings Inc from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.52 Billion | +18.90% |
| 2024-12-31 | $1.28 Billion | +16.16% |
| 2023-12-31 | $1.10 Billion | +13.64% |
| 2022-12-31 | $966.11 Million | +36.65% |
| 2021-12-31 | $707.01 Million | +20.88% |
| 2020-12-31 | $584.90 Million | +40.33% |
| 2019-12-31 | $416.79 Million | +10.19% |
| 2018-12-31 | $378.23 Million | -15.42% |
| 2017-12-31 | $447.19 Million | +21.39% |
| 2016-12-31 | $368.39 Million | -35.43% |
| 2015-12-31 | $570.57 Million | -17.90% |
| 2014-12-31 | $694.94 Million | -- |
About Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medica… Read more